fucoxanthinol and Atrophy

fucoxanthinol has been researched along with Atrophy* in 1 studies

Other Studies

1 other study(ies) available for fucoxanthinol and Atrophy

ArticleYear
Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes.
    Molecular biology reports, 2020, Volume: 47, Issue:4

    The combination of sarcopenia and obesity (i.e., sarcopenic obesity) is more strongly associated with disability and metabolic/cardiovascular diseases than obesity or sarcopenia alone. Therefore, countermeasures that simultaneously suppress fat gain and muscle atrophy to prevent an increase in sarcopenic obesity are warranted. The aim of this study was to investigate the simultaneous effects of fucoxanthinol (FXOH) on fat loss in mature adipocytes and the inhibition of atrophy and loss in myotubes induced by oxidative stress. C2C12 myotubes were treated with FXOH for 24 h and further incubated with hydrogen peroxide (H

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Atrophy; beta Carotene; Cell Line; Fatty Acids; Hydrogen Peroxide; Lipolysis; Metabolic Diseases; Mice; Muscle Fibers, Skeletal; Muscular Atrophy; Obesity; Oxidative Stress; Triglycerides

2020